Teva Pharmaceutical Industries Limited (TEVA)
$42.61+0.83+1.99%Nov 6
Loading chart…
M.Cap$49.7B
Dividends—
Next report27 Jan, before open
Forecast
Target
P/E22.0
P/S2.95
P/B6.22
5-y avg sales growth+0.7%
Debt / EBITDA5.53
ROE17.8%
Altman Z-score0.80 (distress)
RSI57
MFI43
Price / MA50+7.9% (high) ↑
Trend pattern
Financial Statements
No data available
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
About

Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and distributes generic medicines, specialty medicines, biopharmaceuticals, and active pharmaceutical ingredients. It focuses on treating diseases in the central nervous system, pain, respiratory, and oncology areas, and offers products in various dosage forms such as tablets, capsules, injectables, and ointments. Teva has a collaboration with MedinCell for developing and commercializing long-acting injectable products.

https://www.tevapharm.com
Beta 0.95